Literature DB >> 23011912

Oxidative stress and myocardial injury in the diabetic heart.

David M Ansley1, Baohua Wang.   

Abstract

Reactive oxygen or nitrogen species play an integral role in both myocardial injury and repair. This dichotomy is differentiated at the level of species type, amount and duration of free radical generated. Homeostatic mechanisms designed to prevent free radical generation in the first instance, scavenge, or enzymatically convert them to less toxic forms and water, playing crucial roles in the maintenance of cellular structure and function. The outcome between functional recovery and dysfunction is dependent upon the inherent ability of these homeostatic antioxidant defences to withstand acute free radical generation, in the order of seconds to minutes. Alternatively, pre-existent antioxidant capacity (from intracellular and extracellular sources) may regulate the degree of free radical generation. This converts reactive oxygen and nitrogen species to the role of second messenger involved in cell signalling. The adaptive capacity of the cell is altered by the balance between death or survival signal converging at the level of the mitochondria, with distinct pathophysiological consequences that extends the period of injury from hours to days and weeks. Hyperglycaemia, hyperlipidaemia and insulin resistance enhance oxidative stress in the diabetic myocardium that cannot adapt to ischaemia-reperfusion. Altered glucose flux, mitochondrial derangements and nitric oxide synthase uncoupling in the presence of decreased antioxidant defence and impaired prosurvival cell signalling may render the diabetic myocardium more vulnerable to injury, remodelling and heart failure.
Copyright © 2012 Pathological Society of Great Britain and Ireland. Published by John Wiley & Sons, Ltd.

Entities:  

Mesh:

Substances:

Year:  2013        PMID: 23011912      PMCID: PMC3620567          DOI: 10.1002/path.4113

Source DB:  PubMed          Journal:  J Pathol        ISSN: 0022-3417            Impact factor:   7.996


  120 in total

1.  Comparison of factors associated with 30-day mortality after coronary artery bypass grafting in patients with versus without diabetes mellitus. Israeli Coronary Artery Bypass (ISCAB) Study Consortium.

Authors:  Y Cohen; I Raz; G Merin; B Mozes
Journal:  Am J Cardiol       Date:  1998-01-01       Impact factor: 2.778

Review 2.  Factors influencing the outcomes of patients with both coronary artery disease and diabetes enrolled in standard cardiac rehabilitation programs: a literature review.

Authors:  Joyce K Miketic; Marilyn Hravnak; Carol S Stilley; Robert J Robertson; Susan M Sereika
Journal:  J Cardiovasc Nurs       Date:  2011 May-Jun       Impact factor: 2.083

3.  Nox4-derived reactive oxygen species mediate cardiomyocyte injury in early type 1 diabetes.

Authors:  Rita M Maalouf; Assaad A Eid; Yves C Gorin; Karen Block; Gladys Patricia Escobar; Steven Bailey; Hanna E Abboud
Journal:  Am J Physiol Cell Physiol       Date:  2011-10-26       Impact factor: 4.249

4.  Cardiac metallothionein synthesis in streptozotocin-induced diabetic mice, and its protection against diabetes-induced cardiac injury.

Authors:  Ye Song; Jianxun Wang; Yan Li; Yibo Du; Gavin E Arteel; Jack T Saari; Y James Kang; Lu Cai
Journal:  Am J Pathol       Date:  2005-07       Impact factor: 4.307

5.  Opening of the mitochondrial permeability transition pore causes depletion of mitochondrial and cytosolic NAD+ and is a causative event in the death of myocytes in postischemic reperfusion of the heart.

Authors:  F Di Lisa; R Menabò; M Canton; M Barile; P Bernardi
Journal:  J Biol Chem       Date:  2000-11-09       Impact factor: 5.157

6.  Oxidative stress in skeletal muscle impairs mitochondrial respiration and limits exercise capacity in type 2 diabetic mice.

Authors:  Takashi Yokota; Shintaro Kinugawa; Kagami Hirabayashi; Shouji Matsushima; Naoki Inoue; Yukihiro Ohta; Sanae Hamaguchi; Mochamad A Sobirin; Taisuke Ono; Tadashi Suga; Satoshi Kuroda; Shinya Tanaka; Fumio Terasaki; Koichi Okita; Hiroyuki Tsutsui
Journal:  Am J Physiol Heart Circ Physiol       Date:  2009-07-17       Impact factor: 4.733

7.  The diabetic disadvantage: historical outcomes measures in diabetic patients undergoing cardiac surgery -- the pre-intravenous insulin era.

Authors:  Jeremiah R Brown; Fred H Edwards; Gerald T O'Connor; Cathy S Ross; Anthony P Furnary
Journal:  Semin Thorac Cardiovasc Surg       Date:  2006

8.  Cardiac ischemia and reperfusion in spontaneously diabetic rats with and without application of EGb 761: I. cardiomyocytes.

Authors:  Rick Schneider; Klaus Welt; Wolfram Aust; Heinz Löster; Günther Fitzl
Journal:  Histol Histopathol       Date:  2008-07       Impact factor: 2.303

9.  Clinical and experimental evidence for oxidative stress as an exacerbating factor of diabetes mellitus.

Authors:  Ryoichi Takayanagi; Toyoshi Inoguchi; Keizo Ohnaka
Journal:  J Clin Biochem Nutr       Date:  2010-12-28       Impact factor: 3.114

10.  Reactive oxygen species (ROS)-induced ROS release: a new phenomenon accompanying induction of the mitochondrial permeability transition in cardiac myocytes.

Authors:  D B Zorov; C R Filburn; L O Klotz; J L Zweier; S J Sollott
Journal:  J Exp Med       Date:  2000-10-02       Impact factor: 14.307

View more
  77 in total

1.  [Effect of dexmedetomidine postconditioning on myocardial ischemia-reperfusion injury and inflammatory response in diabetic rats].

Authors:  Jing Hu; Xiao-Yu Gu; Yan Meng; Ya Wang; Qin Gao; Zheng-Hong Li; Xiao-Hong Li; Xiang-Yang Cheng
Journal:  Nan Fang Yi Ke Da Xue Xue Bao       Date:  2017-11-20

2.  Akap1 deficiency exacerbates diabetic cardiomyopathy in mice by NDUFS1-mediated mitochondrial dysfunction and apoptosis.

Authors:  Bingchao Qi; Linjie He; Ya Zhao; Ling Zhang; Yuanfang He; Jun Li; Congye Li; Bo Zhang; Qichao Huang; Jinliang Xing; Fei Li; Yan Li; Lele Ji
Journal:  Diabetologia       Date:  2020-02-19       Impact factor: 10.122

3.  [Poly(ADP-ribose) polymerases-1 inhibitor MRL-45696 alleviates DNA damage after myocardial ischemia-reperfusion in diabetic rats].

Authors:  Zhonghua Ji; Lulu Zeng; Yongjun Cheng; Genqiang Liang
Journal:  Nan Fang Yi Ke Da Xue Xue Bao       Date:  2018-07-30

4.  Small Extracellular Microvesicles Mediated Pathological Communications Between Dysfunctional Adipocytes and Cardiomyocytes as a Novel Mechanism Exacerbating Ischemia/Reperfusion Injury in Diabetic Mice.

Authors:  Lu Gan; Dina Xie; Jing Liu; Wayne Bond Lau; Theodore A Christopher; Bernard Lopez; Ling Zhang; Erhe Gao; Walter Koch; Xin-Liang Ma; Yajing Wang
Journal:  Circulation       Date:  2020-01-10       Impact factor: 29.690

5.  Inflammation, wound repair, and fibrosis: reassessing the spectrum of tissue injury and resolution.

Authors:  Eric S White; Alberto R Mantovani
Journal:  J Pathol       Date:  2013-01       Impact factor: 7.996

Review 6.  Metformin therapy in diabetes: the role of cardioprotection.

Authors:  Saloua El Messaoudi; Gerard A Rongen; Niels P Riksen
Journal:  Curr Atheroscler Rep       Date:  2013-04       Impact factor: 5.113

7.  Therapeutic inhibition of mitochondrial reactive oxygen species with mito-TEMPO reduces diabetic cardiomyopathy.

Authors:  Rui Ni; Ting Cao; Sidong Xiong; Jian Ma; Guo-Chang Fan; James C Lacefield; Yanrong Lu; Sydney Le Tissier; Tianqing Peng
Journal:  Free Radic Biol Med       Date:  2015-11-11       Impact factor: 7.376

Review 8.  Treating Diabetes in Patients with Heart Failure: Moving from Risk to Benefit.

Authors:  Ersilia M DeFilippis; Michael M Givertz
Journal:  Curr Heart Fail Rep       Date:  2016-06

9.  The Classically Cardioprotective Agent Diazoxide Elicits Arrhythmias in Type 2 Diabetes Mellitus.

Authors:  Chaoqin Xie; Jun Hu; Lukas J Motloch; Basil S Karam; Fadi G Akar
Journal:  J Am Coll Cardiol       Date:  2015-09-08       Impact factor: 24.094

10.  Effects of neonatal dexamethasone administration on cardiac recovery ability under ischemia-reperfusion in 24-wk-old rats.

Authors:  Xinli Jiang; Huijie Ma; Chunguang Li; Yue Cao; Yan Wang; Yi Zhang; Yan Liu
Journal:  Pediatr Res       Date:  2016-03-18       Impact factor: 3.756

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.